The Dementia Discovery Fund (DDF)—managed by healthcare fund manager SV Health Investors—has announced the final closing of ...

Earlier this month, the US Department of Health and Human Services (HHS) said it would require all future vaccines to undergo ...

Pharmasyntez, one of Russia’s leading drugmakers, plans a significant expansion of its portfolio of innovative drugs in the ...

Swiss reproductive and women’s health medicines specialist ReproNovo today announced the successful closing of a $65 million ...

US biotechs Protagenic Therapeutics (Nasdaq: PTIX) and Phytanix Bio have entered into a definitive share exchange agreement ...

North Carolina, USA-based vTv Therapeutics (Nasdaq: VTVT) has announced that screening has been reinitiated in the company’s ...

UK-based Juvenescence, a clinical stage AI-enabled biotech company, has secured a total of $76 million in the first-close of ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) presented long-term findings from the 24-month open-label extension of the ...

US biotech company SparX Biopharmaceutical has signed a research agreement with Mitsubishi Tanabe Pharma America aimed at ...

German antibody drug conjugate (ADC) specialist Tubulis announced that the first program from its 2023 licensing accord with ...

South Korean vaccine maker SK Bioscience has secured a final court victory over US pharma major Pfizer in a long-running ...

Major progress has been made in delivering a more efficient and adaptable regulatory framework for clinical trials, and ...